Ensysce Biosciences (ENSC) Total Debt (2019 - 2025)
Ensysce Biosciences' Total Debt came in at $306,708 for Q4 2025, up 1.7% from $301,660 a year earlier but down 20.9% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Total Debt (2019 - 2025) Analysis & Trends
Going back to Q4 2019, Ensysce Biosciences' Total Debt data covers 22 quarters.
- Total Debt carries a five-year compound annual growth rate of -42.3% (FY2020 to FY2025).
- Going back by year, Total Debt was $301,660 in FY2024 (-64.7%), $854,697 in FY2023 (-80.6%), $4.41 million in FY2022 (-74.4%) and $17.19 million in FY2021 (+257.3%).
- The five-year range for quarterly Total Debt is $245,973 (Q1 2024) to $17.19 million (Q4 2021).
- Year-over-year, Total Debt increased in five of the last seven quarters, with an average decline of 7.5%.
- The fastest year-over-year change in Total Debt over five years came in Q3 2021 (growth of 767.4%), and the weakest in Q3 2023 (a decline of 96.1%).
- Business Quant data shows ENSC's Total Debt at $387,702 (Q3 2025), $424,521 (Q2 2025) and $257,383 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Ensysce Biosciences | 1.30 Mn | -9.94 Mn | - | 306,708.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 306,708.00 |
| Sep 30, 2025 | 387,702.00 |
| Jun 30, 2025 | 424,521.00 |
| Mar 31, 2025 | 257,383.00 |
| Dec 31, 2024 | 301,660.00 |
| Sep 30, 2024 | 387,176.00 |
| Jun 30, 2024 | 454,463.00 |
| Mar 31, 2024 | 245,973.00 |
| Dec 31, 2023 | 854,697.00 |
| Sep 30, 2023 | 350,932.00 |
| Jun 30, 2023 | 445,738.00 |
| Dec 31, 2022 | 8.81 Mn |
| Sep 30, 2022 | 19.29 Mn |
| Jun 30, 2022 | 5.67 Mn |
| Mar 31, 2022 | 16.19 Mn |
| Dec 31, 2021 | 38.03 Mn |
| Sep 30, 2021 | 10.78 Mn |
| Jun 30, 2021 | 466,055.00 |
| Dec 31, 2020 | 4.25 Mn |
| Sep 30, 2020 | 566,268.00 |
API Access
Ensysce Biosciences Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();